Summary
OBJECTIVE: To determine the prevalence of late complications in a large clinical sample of type 2 diabetic patients in Austria. METHODS: Data of all patients with type 2 diabetes entered into the database of the Forum for Quality Systems in Diabetes Care Austria (FQSD-A) between 1 January 1997 and 1 September 2007 were used for the analyses. RESULTS: Data from 23,641 persons with Type 2 Diabetes Mellitus were collected. Patients were 66.3 ± 11.5 years old, with an average diabetes duration of 8.0 ± 8.5 years. Prevalence of blindness, amputation, myocardial infarction or bypass, stroke and end stage renal failure was 0.9%, 2.3%, 12.2%, 8.7% and 0.8%, respectively. CONCLUSIONS: Prevalence of late diabetic complications in Austria is high compared with other European countries. The management of persons with Type 2 Diabetes should be further optimized to reduce the incidence of late complications of diabetes.
Zusammenfassung
ZIELSETZUNG: Ziel dieser Arbeit ist es, die Prävalenz von diabetischen Spätkomplikationen unter österreichischen Patienten mit Diabetes Mellitus Typ 2 anhand von im Rahmen einer Qualitätssicherungs-Initiative gewonnenen Daten zu bestimmen. METHODIK: Analyse der Daten aller Personen mit diagnostiziertem Diabetes Mellitus Typ 2, die in der Datenbank des Forums für Qualitätssicherung in der Diabetologie Österreich (FQSD-Ö) zwischen 1.1.1997 und 1.9.2007 dokumentiert wurden. ERGEBNISSE: Insgesamt wurden 23.641 Patienten mit Typ-2-Diabetes dokumentiert. Die Patienten waren im Schnitt 66,3 ± 11,5 Jahre alt, mit einer Diabetesdauer von 8,0 ± 8,5 Jahren. Von Blindheit waren 0,9 %, von einer Amputation 2,3 %, von Herzinfarkt oder Bypass 12,2 %, von Schlaganfall 8,7 % und von Nierenversagen 0,8 % der Patienten betroffen. SCHLUSSFOLGERUNGEN: Die Prävalenz der diabetischen Spätkomplikationen in der ausgewerteten österreichischen Population ist hoch, jedoch vergleichbar mit anderen europäischen Ländern. Die Behandlung von Patienten mit Diabetes in Österreich muss weiterhin optimiert werden, um das Auftreten von Spätschäden zu vermindern.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
Literatur
King H, Aubert RE, Herman WH. Global burden of diabetes, 1995–2025: prevalence, numerical estimates, and projections. Diabetes Care, 21: 1414–1431, 1998
Massi-Benedetti M. The cost of diabetes Type II in Europe: the CODE-2 Study. Diabetologia. 45: S1–S4, 2002
Leubner H. Statistical data from the diabetic care and control station of the Medical University Clinic in Innsbruck. Wien Klin Wochenschr, 78: 739–741, 1966
Derfler K, Waldhausl W, Zyman HJ, et al. Diabetes care in rural area: clinical and metabolic evaluation. Diabetes Carel, 9: 509–517, 1986
Muhlhauser I, Sulzer M, Berger M. Quality assessment of diabetes care according to the recommendations of the St. Vincent Declaration: a population-based study in a rural area of Austria. Diabetologia, 35: 429–435, 1992
Renders CM, Valk GD, Griffin SJ, et al. Interventions to improve the management of diabetes in primary care, outpatient, and community settings: a systematic review. Diabetes Care, 24: 1821–1833, 2001
A desktop guide to Type 2 diabetes mellitus. European Diabetes Policy Group 1999. Diabet Med, 16: 716–730, 1999
Thivolet C, el Farkh J, Petiot A et al. Measuring vibration sensations with graduated tuning fork. Simple and reliable means to detect diabetic patients at risk of neuropathic foot ulceration. Diabetes Care, 13: 1077–1080, 1990
Boulton AJ, Gries FA, Jervell JA. Guidelines for the diagnosis and outpatient management of diabetic peripheral neuropathy. Diabet Med, 15: 508–514, 1998
Edlinger R, Auinger M, Prager R. Diabetische Nephropathie. Acta Med Austriaca, 31: 175–178, 2004
R Development Core Team. R: A Language and Environment for Statistical Computing. http://www.r-project.org. Cited 10.7.2008
de Groot M, Anderson R, Freedland KE et al. Association of depression and diabetes complications: a meta-analysis. Psychosom Med, 63: 619–630, 2001
Anderson RJ, Freedland KE, Clouse RE et al. The prevalence of comorbid depression in adults with diabetes: a meta-analysis. Diabetes Care, 24: 1069–1078, 2001
Rakovac I, Gfrerer RJ, Habacher W, et al. Screening of depression in patients with diabetes mellitus. Diabetologia, 47: 1469–1470, 2004
Liebl A, Mata M, Eschwege E. Evaluation of risk factors for development of complications in Type II diabetes in Europe. Diabetologia, 45: S23–S28, 2002
Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. UK Prospective Diabetes Study Group. BMJ, 317: 703–713, 1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet, 352: 837–853, 1998
Gaede P, Vedel P, Larsen N, et al. Multifactorial intervention and cardiovascular disease in patients with type 2 diabetes. N Engl J Med, 348: 383–393, 2003
Williams R, Van Gaal L, Lucioni C. Assessing the impact of complications on the costs of Type II diabetes. Diabetologia, 45: S13–S17, 2002
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Rakovac, I., Plank, J., Jeitler, K. et al. Gesundheitsstatus der Typ-2-Diabetiker in Österreich aus der Sicht einer Qualitätssicherungs-Initiative. Wien Med Wochenschr 159, 126–133 (2009). https://doi.org/10.1007/s10354-009-0659-7
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/s10354-009-0659-7